Targeting malignant B cells of lymphoma and leukemia with genetically engineered T-cell clones

By Jensen MC  

Cytotherapy, Vol. 4, Iss. 5, 2002-09 ,pp. : 443-444

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Selection of autologous CD4⁺ T-cells for adoptive T-cell substitution in patients with CD23⁺ B-cell CLL

By Dettke M   Berger R   Jurko S   Mitterbauer G   Schwarzmeier JD   Höcker P  

Cytotherapy, Vol. 4, Iss. 2, 2002-03 ,pp. : 119-125

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Expansion of human CMV-specific cytotoxic T lymphocytes to a clinical scale: a simple culture system using tetrameric HLA-peptide complexes

By Watanabe N   Kamachi Y   Koyama N   Hama A   Liang J   Nakamura Y   Yamamoto T   Isomura M   Kudo K   Kuzushima K   Kojima S  

Cytotherapy, Vol. 6, Iss. 5, 2004-10 ,pp. : 514-522

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Virus variation, escape from cytotoxic T lymphocytes and human retroviral persistence

By Gould K.G.   Bangham C.R.M.  

Seminars in Cell and Developmental Biology, Vol. 9, Iss. 3, 1998-06 ,pp. : 321-328

Academic Press

Access to resources Recommend Favorite

Human Vδδ1 γγδδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells

By Siegers Gabrielle M.   Dhamko Helena   Wang Xing-Hua   Mathieson A. Mark   Kosaka Yoko   Felizardo Tania C.   Medin Jeffrey A.   Tohda Shuji   Schueler Julia   Fisch Paul   Keating Armand  

Cytotherapy, Vol. 13, Iss. 6, 2011-07 ,pp. : 753-764

Ashgate Publishing Ltd

Access to resources Recommend Favorite